Diabetes & aspirin
This article was originally published in The Tan Sheet
Executive Summary
Nearly half of American adults with diabetes are not using aspirin therapy to reduce their risk of recurrent heart attack or stroke, nor have they discussed such therapy with their physician, according to a survey released Nov. 21 by the American College of Preventive Medicine. Results were drawn from an eight-day online survey of 1,299 consumers over the age of 40 that was conducted in October 2004. The survey was conducted by Harris Interactive and was supported by an unrestricted educational grant from Bayer Healthcare. Approximately 15% of the respondents indicated they have diabetes, which places them at higher risk of cardiovascular-related events, according to the American Diabetes Association. While nearly half of the group with diabetes considered themselves "extremely knowledgeable" about aspirin, only 25% agreed that "the benefits of aspirin therapy strongly outweigh the risks"...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.